Patient with kearns-sayre syndrome exhibiting abnormal magnetic resonance image of the brain

Journal of Neuro-Ophthalmology

Volumn 18, Issue 4, 1998, Pages 284-288

  Kamata, Yuko ^a   Mashima, Yukihiko ^a   Yokoyama, Masako ^a   Tanaka, Kortaro ^a   Goto, Yu Ichi ^b   Oguchi, Yoshihisa ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

Brain magnetic resonance imaging; Flecked retina; Kearns Sayre syndrome; NITDNA deletion; Somatosensory evoked potential; Visual evoked potential

Indexed keywords

EID: 84975461243     PISSN: 10708022     EISSN: 15365166     Source Type: Journal    
DOI: 10.1097/00041327-199812000-00014     Document Type: Article

References (34)

1. Kearns TP, Sayrc CP. Retinitis pigmentosa, external ophthalmoplegia and complete heart block. Arch Ophthalmol 1958;60: 280-9.
2. Kearns TP. External ophthalmoplegia, pigmentary degeneration of the retina, and cardiomyopathy: a newly recognized syndrome. Trans Am Ophthalmol Soc 1965;63: 559-625.
3. Bercnberg RA, Pellock JM, DiMauro S, et al. Lumping or splitting? “Ophthalmoplcgia-plus” or Kearns-Sayre syndrome? Ami Neurol 1977;1: 37-54.
4. Goto Y, Koga Y, Horai S, Nonaka I. Chronic progressive external ophthalmoplegia: a correlative study of mitochondrial DNA deletions and their phenotypie expression in muscle biopsies. J Neurol Set 1990;100: 63-9.
5. Horwitz SJ, Roessmann U. Kearns-Sayrc syndrome with hypoparathyroidism. Ami Neurol 1978;3: 513-8.
6. Olson W, Engel WK, Walsh GO, Einaugler R. Oculocraniosomatic neuromuscular disease with “ragged-red” fibers: histochemical and ultrastruetural changes in limb muscles of a group of patients with idiopathic progressive external ophthalmoplegia. Arch Neurol 1972;26: 193-211.
7. Morgan-Hughes JA, Darveniza P, Landon DN, et al. A mitochondrial myopathy with a deficiency of respiratory chain NADH-CoQ reductase activity. J Neurol Sei 1979;43: 27-46.
8. DiMauro S, Bonilla E, Zeviani M, et al. Mitochondrial myopathics. Ann Neurol 1985;17: 521-38.
9. Zeviani M, Monies CT, DiMauro S, et al. Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology 1988;38: 1339-46.
10. Monies CT, DiMauro S, Zeviani M, et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med 1989;320: 1293-9.
11. Eagle RC, Hedges TR, Yanoff M. The atypical pigmentary retinopathy of Kearns-Sayre syndrome. A light and electron microscopic study. Ophthalmology 1982;89: 1433-40.
12. Goto Y, Nishino I, Horai S, Nonaka I. Deletion of DNA fragments encompassing the deletion junction of mitochondrial genome. Bio-chem Biophys Res Commun 1996;222: 215-9.
13. Wallace DC. Mitochondrial DNA mutations in diseases of energy metabolism. J Bioenerg Biomembr 1994;26: 241-50.
14. Johns DR. Mitochondrial DNA and disease. N Engl J Med 1995;333: 638-44.
15. Rötig A, Cormier V, Blanche S, et al. Pearson’s marrow-pancreas syndrome. A multisystem mitochondrial disorder in infancy. J Clin Invest 1990;86: 1601-8.
16. Koerner F, Schlote W. Chronic progressive external ophthalmoplegia. Association with retinal pigmentary changes and evidence in favor of ocular myopathy. Arch Ophthalmol 1972;88: 155-66.
17. Bastiaensen LAK. Pigment changes of the retina in chronic progressive external ophthalmoplegia (CPEO). Acta Ophthalmol 1978;(Suppl) 138: 5-36.
18. Tsuyama Y, Adachi-Usami E, Takeda N. A case of Kearns-Shy syndrome with later onset. Ophthalmologica 1993;206: 149-51.
19. Small KW, Letson R, Scheinman J. Ocular findings in primary hyperoxaluria. Arch Ophthalmol 1990;108: 89-93.
20. Kaiser-Kupfer MI, Caruso RC, Minkler DS, Gahl WA. Long-term ocular manifestations in nephropathic cystinosis. Arch Ophthalmol 1986;104: 706-11.
21. Gilbert WR, Smith JL, Nyhan WL. The Sjögren-Larsson syndrome. Arch Ophthalmol 1969;80: 308-16.
22. Gass JDM, Taney BS. Flecked retina associated with café au lait spots, microcephaly, epilepsy, short stature, and ring 17 chromosome. Arch Ophthalmol 1994;112: 738-9.
23. Mullie MA, Harding AE, Petty RKH, Ikeda H, Morgan-Hughes JA, Sanders MD. The retinal manifestations of mitochondrial myopathy. A study of 22 cases. Arch Ophthalmol 1985;103: 1825-30.
24. Heynen H, Wachtmeister L, van Norren D. Origin of the oscillatory potentials in the primate retina. Vision Res 1985;25: 1365-73.
25. Bresnick GH. Electroretinography and color vision in diabetes mellitus. In: Crcpaldi G, Cunha-Vas JG, Fedele D, et al, eds. Microvascular and neurological complications of diabetes. Pa-dova: Livina Press, 1987: 17-33.
26. Berdjis H, Heider W, Demisch K. ERG and VECP in chronic progressive external ophthalmoplegia (CPEO). Doc Ophthalmol 1985;60: 427-34.
27. Ogasawara S, Nishikawa Y, Yorifuji S, et al. Treatment of Kearns-Sayre syndrome with coenzyme QH). Neurology 1986;36: 45-53.
28. Vcrsino M, Piccolo G, Callieco R, et al. Multimodal evoked potentials in progressive external ophthalmoplegia with mitochondrial myopathy. Acta Neurol Scand 1991;84: 107-10.
29. Sartucci F, Rossi B, Tognori G, Siciliano G, Guerrini V, Murri L. Evoked potentials in the evaluation of patients with mitochondrial myopathy. Eur Neurol 1993;33: 428-35.
30. Schubert M, Zierz S, Dengler R. Central and peripheral nervous system conduction in mitochondrial myopathy with chronic progressive external ophthalmoplegia. Electroencephalogr Clin Neu-rophysiol 1994;90: 304-12.
31. Elsås T, Rinck PA, Isaksen C, Nilscn G, Schjctnc OB. Cerebral nuclear magnetic resonance (MRI) in Kearns syndrome. Acta Ophthalmol 1988;66: 469-73.
32. Dcmange P, Gia HP, Kalifa G, Sellier N. MR of Kearns-Sayre syndrome. AJNR Am J Neuroradiol 1989;10(Suppl): S91.
33. Nakagawa E, Hirano S, Yamauchi H, Goto Y, Nonaka I, Takashima S. Progressive brainstem and white matter lesions in Kearns-Sayre syndrome: a case report. Brain Dev 1994;16: 416-8.
34. Crisi G, Ferrari G, Merelli E, Cocconcelli P. MRI in a case of Kearns-Sayre syndrome confirmed by molecular analysis. Neuroradiology 1994;36: 37-8.